Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 817 results for "bayer ag"

Bayer AG (BAYRY) Announces Quarterly Results
American Banking News

Bayer's (BAYRY) CEO Marijn Dekkers on Q2 2014 Results - Earnin...

Bayer AG ( OTCPK:BAYRY ) Q2 2014 Earnings Conference Call July 30, 2014 8:00 AM ET Operator Ladies and gentlemen, thank you for standing by. Welcome to Bayer's Investor and Analyst Conference Call on the Second Quarter 2014 Results. Seeking Alpha, 5 hours ago
Bayer updates guidance after Q2 results Seeking Alpha, 20 hours ago
Bayer AG (BAYRY) Announces Quarterly Results American Banking News, 11 hours ago

98 images for bayer ag

American Banking News, 3 weeks ago
4 Traders, 4 weeks ago
BioSpace, 1 month ago
12 News Now, 1 month ago
Yahoo! Finance, 1 month ago
4 Traders, 1 month ago
Greenwich Time, 1 month ago
bloomberg.com, 3 weeks ago
Scottrade, 1 week ago
ABC News 4 Charleston, 2 weeks ago
BusinessWeek

Bayer Earnings Rise as New Drugs Offset Stronger Euro

Bayer AG (BAYN)'s second-quarter earnings rose on improved sales of new heart, cancer and eye drugs even as a stronger euro and the weaker performance of older products restrained profit. Earnings before interest, taxes, depreciation, amortization ...
 BusinessWeek20 hours ago Bayer Second-Quarter Earnings Rise on Sales of New Medicines  Washington Post1 day ago Bayer posts higher sales earnings  Big News Network3 hours ago Bayer's Second-Quarter Earnings Rise as New Drugs Offset Euro  La Repubblica20 hours ago
[x]  

BRIEF-Bayer's Regorafenib wins EU approval for treatment of gastrointestinal tumors

(Reuters) - Bayer AG : * Says regorafenib (Stivarga) approved in the European union for the treatment of gastrointestinal stromal tumors Source
 Reuters23 hours ago

Bayer's Stivarga gets go-ahead from European regulators to treat gastrointestinal tumors

German pharma group Bayer AG (ETR:BAYN) said Wednesday that the European Commission (EC) had given the green light to Stivarga (regorafenib) to treat adults with unresectable or metastatic gastrointestinal stromal tumours (GIST) who progressed on or ...
 MedCity News15 hours ago Bayer : Receives EU Approval for Stivarga for Tumor Treatment  4 Traders22 hours ago Bayer Receives EU Approval for Stivarga for Tumor Treatment  ADVFN India16 hours ago
[x]  

BAYER : Profit Rises But Outlook Tweaked By Euro Strength

FRANKFURT-- Bayer AG's second-quarter net profit increased 14%, helped by robust demand for its latest drugs and crop protection products, but the German company tweaked its full-year outlook to reflect the strength of the euro against other ...
 4 Traders23 hours ago Bayer Profit Rises But Outlook Tweaked By Euro Strength  ADVFN India23 hours ago
RTTNews.com

Bayer Q2 Profit Rises - Quick Facts

German conglomerate Bayer (BYR.L,BAYRY.PK,BAYZF.PK) reported that its second-quarter net income climbed by 13.3 percent to 953 million euros from 841 million euros last year. Core earnings per share were 1.53 euros, compared to 1.54 euros in the ...
 RTTNews.com1 day ago Bayer Q2 Profit Rises 13%  RTTNews.com1 day ago

BRIEF-Bayer's Eylea receives FDA approval for the treatment of diabetic macular edema

8:03am BST July 30 (Reuters) - Bayer AG : * Says Eylea receives FDA approval for the treatment of diabetic
 Reuters UK1 day ago
RTTNews.com

UPDATE 2-Merck Q2 profit tops estimates on strong consumer sales

(Adds product sales, details on Bayer, Idenix deals) July 29 (Reuters) - Merck & Co Inc reported better-than-expected quarterly results on Tuesday, with sales of consumer products and medicines for arthritis and HIV helping to offset the impact ...
 CNBC1 day ago UPDATE 3-Merck quarterly profit beats estimates; shares gain  Reuters UK1 day ago Merck Q2 profit tops estimates on strong consumer sales  Yahoo! Finance1 day ago Merck Beats Views  FOXBusiness.com1 day ago
[x]  
Securities Technology Monitor

There's Something in the Water: Global Icon, Berocca®, Arrives on U.S. Soil with New Special Formula and Flavor

Excitement is bubbling up nationwide and it's all about the fizz. Today, Bayer HealthCare announces the nationwide arrival of Berocca - an energy support supplement in an effervescent tablet that, when dropped into a glass of water, unleashes a ...
 Individual.com1 day ago
[x]  
Scottrade

Global Retinal Vein Occlusion Market 2014-2018: Key Vendors are Bayer, F. Hoffmann-La Roche, Novartis and Regeneron Pharmaceuticals

From the Wires Jul. 30, 2014 08:16 AM DUBLIN , July 30, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Global Retinal Vein Occlusion Market 2014-2018" report to their offering. ...
 Sys-Con India17 hours ago Research and Markets: Global Retinal Vein Occlusion Market 2014-2018: Key Vendors are Bayer, F. Hoffmann-La Roche, Novartis and Regeneron Pharmaceuticals  TMC Net18 hours ago RESEARCH AND MARKETS : Global Retinal Vein Occlusion Market 2014-2018: Key Vendors are Bayer, F. Hoffmann-La Roche, Novartis and Regeneron Pharmaceuticals  4 Traders19 hours ago Bayer CropScience AG : Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report  MarketResearch.com4 days ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less